Degenerative Neurological and Neuromuscular Disease
Open access peer-reviewed scientific and medical journals.
Dove Medical Press is now a member of the Open Access Initiative
An Author's Guide
A guide to help authors get their paper published.
Support Open Access and Dove Press
Promotional Article Monitoring - further details
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Editor-in-Chief: Professor Thomas Müller
Professor Thomas Müller is the Head of the Department of Neurology and Consultant in Neurology/Psychiatry at St. Joseph Hospital Berlin-Weissensee, Germany.
His research interests include:
Use of various functional, morphologic brain imaging techniques (MRI, fMRI, SPECT, PET) in the diagnosis and evaluation of progression of neurodegenerative disorders, i.e. Parkinson’s disease in combination with various simple instrumental tools.
Performance of neuropharmacological trials with putative neuroprotective or neuroregnerative compounds in neurodegenerative disease at least partially in close cooperation with the pharmaceutical industry.
Investigations of neuroophthalmologic changes in neurodegnerative disorders and the impact of dopaminergic compounds on visual function.
Studies on the pathogenesis of Parkinson’s disease, dystonia, Huntington’s disease, vascular brain disease and dementia with search for genetic, metabolic and environmental biomarkers and risk factors for neurodegenerative diseases.
Performance of epidemiologic, pharmacokinetic and pharmacologic trials on the efficacy of antiparkinsonian agents.
Research on neuropsychological changes in neurodegenerative diseases.
Development and use of instrumental procedures and various reaction time paradigms for the evaluation of drug response in Parkinson’s disease.
Research on levodopa induced vascular risk factors in neurodegenerative diseases with specific evaluation of genetic polymorphisms of drug metabolizing enzymes.
Evaluation of the clinical efficacy of intrathecally administered steroid preparation in the treatment of progressive multiple sclerosis with predominant spinal symptoms.
Studies on fine motor skills and control in Parkinson‘s disease and related movement disorders.
- MLA'14 -
May 16–21, 2014